MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579 | -83.8% | 13,293 | -86.5% | 0.01% | -79.3% |
| Q2 2023 | $3,567 | -41.4% | 98,738 | -39.7% | 0.03% | -42.0% |
| Q1 2023 | $6,088 | +591.8% | 163,742 | +743.4% | 0.05% | +284.6% |
| Q4 2022 | $880 | -100.0% | 19,414 | -50.7% | 0.01% | -63.9% |
| Q3 2022 | $2,752,000 | -14.0% | 39,402 | +1.2% | 0.04% | -10.0% |
| Q1 2022 | $3,201,000 | +15.6% | 38,927 | +106.2% | 0.04% | +37.9% |
| Q4 2021 | $2,770,000 | -33.3% | 18,881 | -26.6% | 0.03% | -37.0% |
| Q2 2021 | $4,153,000 | +206.7% | 25,713 | +225.4% | 0.05% | +130.0% |
| Q1 2021 | $1,354,000 | -25.6% | 7,902 | -4.7% | 0.02% | +11.1% |
| Q4 2020 | $1,821,000 | -0.7% | 8,293 | -65.2% | 0.02% | -82.2% |
| Q1 2020 | $1,834,000 | – | 23,854 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |